↓ Skip to main content

A Phase II Study of ABT-510 (Thrombospondin-1 Analog) for the Treatment of Metastatic Melanoma

Overview of attention for article published in American Journal of Clinical Oncology: Cancer Clinical Trials, June 2007
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

patent
64 patents
wikipedia
2 Wikipedia pages

Readers on

mendeley
49 Mendeley